Redmile Group, LLC - 20 Dec 2024 SCHEDULE 13D/A Report for FATE THERAPEUTICS INC Common Stock, $0.001 par value per share (FATE)

Filing Manager
Redmile Group, LLC
Reporting Manager
Redmile Group, LLC
Security
FATE THERAPEUTICS INC Common Stock, $0.001 par value per share
Symbol
FATE
Shares outstanding
119,574,725 shares
Disclosed Ownership
17,816,634 shares
Ownership
15%
Form type
SCHEDULE 13D/A
Filing time
26 Dec 2024, 21:00:09 UTC
Date of event
20 Dec 2024
Next filing
03 Jul 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Redmile Group, LLC 15% 17,816,634 0 17,816,634 /s/ Jeremy C. Green Jeremy C. Green/Managing Member 0001425738
Jeremy C. Green 15% 17,816,634 0 17,816,634 /s/ Jeremy C. Green Jeremy C. Green 0001650527
RedCo II Master Fund, L.P. 8.5% 9,787,689 0 9,787,689 /s/ Jeremy C. Green - REDCO II (GP), LLC, ITS GENERAL PARTNER Jeremy C. Green/Managing Member 0001921783